Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Antisense Research and Development|January 1, 1993
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trialE Bayever, P L Iversen, M R Bishop, et al.
South Asian Journal of Cancer|May 4, 2018
Practical consensus recommendatons for Paget's disease in breast cancerA Gaurav, V Gupta, R Koul, et al.
Contrast Media & Molecular Imaging|June 30, 2010
Patlak plot analysis CT-GFR for the determination of renal function: comparison of normal dogs with autologous kidney transplant dogsK Alexander, S Authier, J R E del Castillo, et al.
Bioorganic & Medicinal Chemistry|November 5, 1998
Development of novel 19F NMR pH indicators: synthesis and evaluation of a series of fluorinated vitamin B6 analoguesS He, R P Mason, S Hunjan, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Clinical Therapeutics|April 1, 2000
Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitusJ K Malone, J R Woodworth, V Arora, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Clinical Radiology|November 18, 2021
Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched studyA Mukund, S V Srinivasan, S Rana, et al.
Journal of Hematotherapy|November 22, 1997
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndromeM R Bishop, J D Jackson, S R Tarantolo, et al.
Pageof 14